Intensive Care Medicine

, Volume 42, Issue 11, pp 1753–1765 | Cite as

Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study)

  • Silvia Calviño Günther
  • Carole Schwebel
  • Rebecca Hamidfar-Roy
  • Agnès Bonadona
  • Maxime Lugosi
  • Claire Ara-Somohano
  • Clémence Minet
  • Leïla Potton
  • Jean-Charles Cartier
  • Aurelien Vésin
  • Magalie Chautemps
  • Lenka Styfalova
  • Stephane Ruckly
  • Jean-François Timsit



To describe all post-insertion complications involving most used intravascular access, and to determine whether the use of a new-generation transparent dressing (3M™ IV Advanced) might reduce their number and impact on ICU patient outcomes.


Patients older than 18, with an expected length of stay ≥48 h and requiring at least one central venous catheter (CVC), arterial catheter (AC), haemodialysis catheter (HDC), pulmonary arterial catheters (PAC) or peripheral venous catheter (PVC) were randomized into two groups: a new-generation transparent dressing, or the hospital’s classical transparent dressing, and were followed daily for any infectious and non-infectious complications. Complications were graduated for severity by an independent international multicentre multidisciplinary panel of practitioners using a Delphi process.


We included 628 patients, 2214 catheters (873 PVCs, 630 CVCs, 512 ACs and 199 HDCs and PACs) and 4836 dressings. Overall incidence rate was of 60.9/1000 catheter-days. The most common complication was dysfunction (34.6/1000 catheter-days), mainly for PVCs (16/1000 catheter-days) and ACs (12.9/1000 catheter-days). Infectious complications incidence rate in CVCs and ACs was of 14.5/1000, mostly due to colonization (14.2/1000 catheter-days). Thrombosis incidence was of 3.8/1000 catheter-days with severe and very severe complications in 16 cases (1.8/1000 catheter-days) and one thrombosis-related death. 3M™ IV Advanced dressing did not decrease the rate of catheters with at least a minor complication [57.37/1000 vs. 57.52/1000 catheter-days, HR 1.03, CI (0.84–1.27), p = 0.81]. Incidence rates for each single complication remained equivalent: infectious [HR 0.93 (0.62–1.40), p = 0.72], deep thrombosis [HR 0.90 (0.39–2.06), = 0.80], extravasation and phlebitis [HR 1.40 (0.69–2.82), p = 0.35], accidental removal [1.07 (0.56–2.04), p = 0.84] and dysfunction [HR 1.04 (0.80–1.35), p = 0.79].


The ADVANCED study showed the overall risk of complications to intravascular catheters in ICU patients being dysfunction, infection and thrombosis. The 3M™ IV Advanced dressing did not decrease complication rates as compared to standard dressings.


Catheter-related complications Safety Adverse event ICU Dressing 


Compliance with ethical standards

Conflicts of interest

This study was financed by a research grant from 3M™ Health Care (Neuss, Germany). The sponsors of the study had no role in study design, data collection, analysis and interpretation, or writing of the report. Sponsors had no role either in the proposal or the election of the Delphi members. Corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. The corresponding author states that there is no further conflict of interest to disclose.

Supplementary material

134_2016_4582_MOESM1_ESM.doc (348 kb)
Supplementary material 1 (DOC 347 kb)
134_2016_4582_MOESM2_ESM.pdf (482 kb)
Supplementary material 2 (PDF 481 kb)


  1. 1.
    Savey A, Machut A (eds) (2012) Institut national de veille sanitaire (INVS) Surveillance des infections nosocomiales en réanimation adulte. Résultats REA-Raisin, France, résultats 2011. INVS, LyonGoogle Scholar
  2. 2.
    Renaud B, Brun-Buisson C (2001) Outcomes of primary and catheter-related bacteremia. A cohort and case-control study in critically ill patients. Am J Respir Crit Care Med 163:1584–1590CrossRefPubMedGoogle Scholar
  3. 3.
    Pittet D, Tarara D, Wenzel RP (1994) Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA 271:1598–1601CrossRefPubMedGoogle Scholar
  4. 4.
    Mermel LA (2011) What is the predominant source of intravascular catheter infections? Clin Infect Dis 52:211–212CrossRefPubMedGoogle Scholar
  5. 5.
    Timsit JF, L’Heriteau F, Lepape A, Francais A, Ruckly S, Venier AG, Jarno P, Boussat S, Coignard B, Savey A (2012) A multicentre analysis of catheter-related infection based on a hierarchical model. Intensive Care Med 38:1662–1672CrossRefPubMedGoogle Scholar
  6. 6.
    Mermel LA (2007) Prevention of central venous catheter-related infections: what works other than impregnated or coated catheters? J Hosp Infect 65(Suppl 2):30–33CrossRefPubMedGoogle Scholar
  7. 7.
    Maki DG, Kluger DM, Crnich CJ (2006) The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 81:1159–1171CrossRefPubMedGoogle Scholar
  8. 8.
    Timsit JF, Bouadma L, Ruckly S, Schwebel C, Garrouste-Orgeas M, Bronchard R, Calvino-Gunther S, Laupland K, Adrie C, Thuong M, Herault MC, Pease S, Arrault X, Lucet JC (2012) Dressing disruption is a major risk factor for catheter-related infections. Crit Care Med 40:1707–1714CrossRefPubMedGoogle Scholar
  9. 9.
    Timsit JF, Farkas JC, Boyer JM, Martin JB, Misset B, Renaud B, Carlet J (1998) Central vein catheter-related thrombosis in intensive care patients: incidence, risks factors, and relationship with catheter-related sepsis. Chest 114:207–213CrossRefPubMedGoogle Scholar
  10. 10.
    Gabriel J (2010) Vascular access devices: securement and dressings. Nurs Stand 24:41–46CrossRefPubMedGoogle Scholar
  11. 11.
    Bausone-Gazda D, Lefaiver CA, Walters SA (2010) A randomized controlled trial to compare the complications of 2 peripheral intravenous catheter-stabilization systems. J Infus Nurs 33:371–384CrossRefPubMedGoogle Scholar
  12. 12.
    Rutledge LF, DeCabooter DP, Walters SA, Bernatchez SF (2015) Catheter securement systems: comparison of two investigational devices to a sutureless securement device, a securement dressing, and sutures in a pig model. Intensive Care Med Exp 3:60CrossRefPubMedGoogle Scholar
  13. 13.
    Ullman AJ, Cooke ML, Mitchell M, Lin F, New K, Long DA, Mihala G, Rickard CM (2016) Dressing and securement for central venous access devices (CVADs): a Cochrane systematic review. Int J Nurs Stud 59:177–196CrossRefPubMedGoogle Scholar
  14. 14.
    Marsh N, Webster J, Mihala G, Rickard CM (2015) Devices and dressings to secure peripheral venous catheters to prevent complications. Cochrane Database Syst Rev CD011070Google Scholar
  15. 15.
    Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Lepape A, Vesin A, Arrault X, Schwebel C, Adrie C, Zahar JR, Ruckly S, Tournegros C, Lucet JC (2012) Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med 186:1272–1278CrossRefPubMedGoogle Scholar
  16. 16.
    Timsit JF, Schwebel C, Bouadma L, Geffroy A, Garrouste-Orgeas M, Pease S, Herault MC, Haouache H, Calvino-Gunther S, Gestin B, Armand-Lefevre L, Leflon V, Chaplain C, Benali A, Francais A, Adrie C, Zahar JR, Thuong M, Arrault X, Croize J, Lucet JC (2009) Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 301:1231–1241CrossRefPubMedGoogle Scholar
  17. 17.
    Lucet JC, Boudama L, Zahar JR, Schwebel C, Geffory A, Pease S, Herault MC, Haouache H, Adrie C, Thuong M, Francais A, Garrouste-Orgeas M, Timsit JF (2010) Infectious risk associated with arterial catheters compared to central venous catheters. Crit Care Med 38:552–559CrossRefGoogle Scholar
  18. 18.
    Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S, Friggeri A, Wallet F, Allou N, Ruckly S, Balayn D, Lepape A, Timsit JF (2015) Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial. Lancet 386:2069–2077CrossRefPubMedGoogle Scholar
  19. 19.
    Minet C, Potton L, Bonadona A, Hamidfar-Roy R, Somohano CA, Lugosi M, Cartier JC, Ferretti G, Schwebel C, Timsit JF (2015) Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis. Crit Care 19:287CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Baskin JL, Pui CH, Reiss U, Wilimas JA, Metzger ML, Ribeiro RC, Howard SC (2009) Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 374:159–169CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Malinoski D, Ewing T, Bhakta A, Schutz R, Imayanagita B, Casas T, Woo N, Margulies D, Barrios C, Lekawa M, Chung R, Bukur M, Kong A (2013) Which central venous catheters have the highest rate of catheter-associated deep venous thrombosis: a prospective analysis of 2,128 catheter days in the surgical intensive care unit. J Trauma Acute Care Surg 74:454–460CrossRefPubMedGoogle Scholar
  22. 22.
    Leung A, Heal C, Perera M, Pretorius C (2015) A systematic review of patient-related risk factors for catheter-related thrombosis. J Thromb Thrombolysis 40:363–373CrossRefPubMedGoogle Scholar
  23. 23.
    Ge X, Cavallazzi R, Li C, Pan SM, Wang YW, Wang FL (2012) Central venous access sites for the prevention of venous thrombosis, stenosis and infection. Cochrane Database Syst Rev 3:CD004084PubMedGoogle Scholar
  24. 24.
    Moretti EW, Ofstead CL, Kristy RM, Wetzler HP (2005) Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. J Hosp Infect 61:139–145CrossRefPubMedGoogle Scholar
  25. 25.
    Betjes MG (2011) Prevention of catheter-related bloodstream infection in patients on hemodialysis. Nat Rev Nephrol 7:257–265CrossRefPubMedGoogle Scholar
  26. 26.
    Wilson P, Lertdumrongluk P, Leray-Moragues H, Chenine-Koualef L, Patrier L, Canaud B (2012) Prevention and management of dialysis catheter complications in the intensive care unit. Blood Purif 34:194–199CrossRefPubMedGoogle Scholar
  27. 27.
    Cicolini G, Bonghi AP, Di Labio L, Di Mascio R (2009) Position of peripheral venous cannulae and the incidence of thrombophlebitis: an observational study. J Adv Nurs 65:1268–1273CrossRefPubMedGoogle Scholar
  28. 28.
    Gonzalez Lopez JL, Arribi Vilela A, Fernandez del Palacio E, Olivares Corral J, Benedicto Marti C, Herrera Portal P (2014) Indwell times, complications and costs of open vs closed safety peripheral intravenous catheters: a randomized study. J Hosp Infect 86:117–126CrossRefPubMedGoogle Scholar
  29. 29.
    Ricard JD, Salomon L, Boyer A, Thiery G, Meybeck A, Roy C, Pasquet B, Le Miere E, Dreyfuss D (2013) Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial. Crit Care Med 41:2108–2115CrossRefPubMedGoogle Scholar
  30. 30.
    Bouza E, Guembe M, Munoz P (2010) Selection of the vascular catheter: can it minimise the risk of infection? Int J Antimicrob Agents 36(Suppl 2):S22–S25CrossRefPubMedGoogle Scholar
  31. 31.
    Fernandez-Ruiz M, Carretero A, Diaz D, Fuentes C, Gonzalez JI, Garcia-Reyne A, Aguado JM, Lopez-Medrano F (2014) Hospital-wide survey of the adequacy in the number of vascular catheters and catheter lumens. J Hosp Med 9:35–41CrossRefPubMedGoogle Scholar
  32. 32.
    Vandijck DM, Labeau SO, Secanell M, Rello J, Blot SI (2009) The role of nurses working in emergency and critical care environments in the prevention of intravascular catheter-related bloodstream infections. Int Emerg Nurs 17:60–68CrossRefPubMedGoogle Scholar
  33. 33.
    Shapey IM, Foster MA, Whitehouse T, Jumaa P, Bion JF (2009) Central venous catheter-related bloodstream infections: improving post-insertion catheter care. J Hosp Infect 71:117–122CrossRefPubMedGoogle Scholar
  34. 34.
    Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D (2000) Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet 355:1864–1868CrossRefPubMedGoogle Scholar
  35. 35.
    Guerin K, Wagner J, Rains K, Bessesen M (2010) Reduction in central line-associated bloodstream infections by implementation of a postinsertion care bundle. Am J Infect Control 38:430–433CrossRefPubMedGoogle Scholar
  36. 36.
    Schears GJ (2006) Summary of product trials for 10,164 patients: comparing an intravenous stabilizing device to tape. J Infus Nurs 29:225–231CrossRefPubMedGoogle Scholar
  37. 37.
    Reynolds H, Taraporella K, Tower M, Mihala G, Tuffaha HW, Fraser JF, Rickard CM (2015) Novel technologies can provide effective dressing and securement for peripheral arterial catheters: a pilot randomised controlled trial in the operating theatre and the intensive care unit. Aust Crit Care 28:140–148CrossRefPubMedGoogle Scholar
  38. 38.
    Webster J, Gillies D, O’Riordan E, Sherriff KL, Rickard CM (2011) Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev CD003827Google Scholar
  39. 39.
    Vokurka S, Bystricka E, Visokaiova M, Scudlova J (2009) Once- versus twice-weekly changing of central venous catheter occlusive dressing in intensive chemotherapy patients: results of a randomized multicenter study. Med Sci Monit 15:CR107–CR110PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg and ESICM 2016

Authors and Affiliations

  • Silvia Calviño Günther
    • 1
  • Carole Schwebel
    • 1
  • Rebecca Hamidfar-Roy
    • 1
  • Agnès Bonadona
    • 1
  • Maxime Lugosi
    • 1
  • Claire Ara-Somohano
    • 1
  • Clémence Minet
    • 1
  • Leïla Potton
    • 1
  • Jean-Charles Cartier
    • 1
  • Aurelien Vésin
    • 2
  • Magalie Chautemps
    • 1
  • Lenka Styfalova
    • 1
  • Stephane Ruckly
    • 2
  • Jean-François Timsit
    • 2
    • 3
    • 4
  1. 1.University Hospital of Grenoble Alpes, Medical Intensive Care UnitAlbert Michallon Teaching HospitalGrenoble Cedex 9France
  2. 2.Albert Bonniot Institute, INSERM U823 “Outcome of Cancer and Critical Illness”GrenobleFrance
  3. 3.Medical and Infectious Diseases Intensive Care UnitAP-HP, Bichat-Claude Bernard Teaching HospitalParisFrance
  4. 4.Inserm Paris-Diderot University-UMR 1137-IAME Team 5-DeSCID: Decision SCiences in Infectious Diseases, Control and CareParisFrance

Personalised recommendations